Who to call at Apimeds Pharmaceuticals US, Inc., and when
Fundz watches for the moments Apimeds Pharmaceuticals US, Inc. starts buying, and tells you who to reach.
- An alert the day Apimeds Pharmaceuticals US, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Apimeds Pharmaceuticals US, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Apimeds Pharmaceuticals US, Inc.. With Fundz connected, it knows.
Apimeds Pharmaceuticals US, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
www.apimedsus.comAI Executive Summary
AI-powered analysis of 8-K filing content
Apimeds Pharmaceuticals amended CEO Erik Emerson's employment agreement, raising his annual base salary to $500,000 and adding a severance package of 24 months' salary and benefits plus immediate equity vesting for termination without cause. The changes strengthen executive retention terms and increase potential severance exposure.
Key Takeaways
Erik Emerson's annual base salary rises to $500,000 effective November 13, 2025.
If the company terminates Emerson without cause, he receives 24 months of base salary and benefits and immediate vesting of all unvested equity, conditioned on signing a release of claims.
2 more takeaways
Related Filings (2)
2 more filings from Apimeds Pharmaceuticals US, Inc. in the last 90 days
Filing Overview
What This Means
Apimeds Pharmaceuticals US, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.